About CORAR
The Council on Radionuclides and Radiopharmaceuticals, Inc. (CORAR) is the trade association and voice of the radionuclide and radiopharmaceutical industry in North America. People around the world each year benefit from the longstanding commitment CORAR’s members make to research and development, manufacturing and distribution of radiopharmaceuticals and radionuclides—which are used as tracers in the diagnosis and treatment of many diseases.
Our Position
CORAR advocates for public policies that impact health care, transportation safety, homeland security, and manufacturing in an effort to expand access to safe and affordable health care treatments for all.
Below you will find links to position papers that we have filed.
CORAR Proposed Compounding Compliance Policy Guide on Radiopharmaceutical Compounding (2/21/14)
CORAR Position on the Security of Supply of Medical Isotopes (7/10/12)
Council on Radionuclides and Radiopharmaceuticals Position Paper on Skin Dose Limits (8/18/08)
Council on Radionuclides and Radiopharmaceuticals Position Paper on Mixed Waste (7/30/08)
Latest News
-
MITA and CORAR Support House Bill to Foster Access to Innovative Medical Imaging https://t.co/Riwxdv6noS #CORAR
-
CORAR Comments on FDA Draft 503B RP Compounding Guidance https://t.co/EJMpjHYcz4 #CORAR
-
CORAR Comments on FDA Draft Nuclear Pharmacy Compounding Guidance https://t.co/Hhcem9KabR #CORAR